Patient Advocacy | Tissuepathology.com

Cancer Survival Rises

Dr. Keith J. Kaplan — Wed, 14 Jan 2026 15:51:58 +0000

From CNN: The five-year cancer survival rate in the US has reached 70% for the first time, according to an American Cancer Society report released yesterday. The figure, based on diagnoses from 2015 to 2021, is up from 49% in the mid-1970s and 63% in the mid-1990s. The ACS attributes the rise to wider and earlier screening, lower smoking […]

The post Cancer Survival Rises first appeared on Tissuepathology.com.

A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis

Erica Goodpaster — Mon, 08 Dec 2025 12:47:56 +0000

A woman underwent a total hysterectomy at Penn based on a cancer misdiagnosis at Lankenau Medical Center. The verdict is the largest so far this year in Philadelphia. A Philadelphia jury reached $35 million verdict last week against Main Line Health and the University of Pennsylvania Health System for a cancer misdiagnosis that led a […]

The post A Philadelphia jury reached $35 million verdict against Main Line Health and Penn Medicine for cancer misdiagnosis first appeared on Tissuepathology.com.

Ibex Obtains CE Mark for Galen Gastric, the World’s First AI-powered Solution for Gastric Cancer Detection

Erica Goodpaster — Mon, 20 Jun 2022 10:34:04 +0000

Ibex: Galen™ Gastric demonstrated outstanding outcomes in detecting gastric cancer in a multi-site study, supporting quality diagnosis, enhanced lab efficiency and quality control Tel Aviv, Israel, June 15, 2022 – Ibex Medical Analytics, the pioneer in AI-powered cancer diagnostics, today announced CE-Mark for the Galen™ Gastric solution that supports pathologists in the detection of various types […]

The post Ibex Obtains CE Mark for Galen Gastric, the World’s First AI-powered Solution for Gastric Cancer Detection first appeared on Tissuepathology.com.

A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.

Erica Goodpaster — Mon, 29 Nov 2021 12:33:51 +0000

Brian Shelton’s life was ruled by Type 1 diabetes. When his blood sugar plummeted, he would lose consciousness without warning. He crashed his motorcycle into a wall. He passed out in a customer’s yard while delivering mail. Following that episode, his supervisor told him to retire, after a quarter century in the Postal Service. He […]

The post A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked. first appeared on Tissuepathology.com.

Olympus Announces First Results of Its AI-Based Pathology Diagnostic Tool for Gastric Cancer

Erica Goodpaster — Tue, 16 Nov 2021 15:40:30 +0000

The AI achieved 100% sensitivity and 50% or more specificity TOKYO, (November 16, 2021)—The results of Olympus’ ongoing joint research program1to create an AI-based pathology diagnostic tool with the potential to streamline pathologists’ workloads were announced at the Japan Society of Digital Pathology Study annual meeting. The diagnostic tool achieved 100% sensitivity2 and 50% or […]

The post Olympus Announces First Results of Its AI-Based Pathology Diagnostic Tool for Gastric Cancer first appeared on Tissuepathology.com.

Pfizer Pledges Shipment of New Antiviral COVID Pill to Israel — Report

Erica Goodpaster — Tue, 16 Nov 2021 12:26:54 +0000

PM and health minister reach agreement with drug company for ‘tens of thousands of doses’; initial data shows almost 90% efficacy Pfizer has pledged a shipment of its experimental antiviral COVID-19 pill to Israel, according to a Saturday television report, a week after the US drugmaker said it was engaged in “active discussion” with 90 […]

The post Pfizer Pledges Shipment of New Antiviral COVID Pill to Israel — Report first appeared on Tissuepathology.com.